Search Results

Adhesion GPCR Consortium: The 11th Adhesion GPCR Workshop. Adhesion GPCRs A correlation study of adhesion G protein-coupled receptors as potential therapeutic targets Services and Cube Biotech Collaborate to Enhance Cryo-EM Enabled Gene to Structure Workflow Domain Therapeutics ACTH-Dependent Cushing’s Syndrome (ADCS) Septerna Presents Preclinical Data at ENDO 2024 Highlighting Therapeutic GPCR Ecosystem

We’ve curated 23 GPCR papers, four industry news, and 3 GPCR job posts! This week's highlight: Drs. GPCR Ecosystem Members! GPCR Access to Dr. Morgan Healthcare Conference Andrew Hopkins appointed CBE by HM King Charles III Voyager Therapeutics GPCR Ecosystem

Check out our curated GPCR coverage for this week, which includes 14 GPCR papers, four industry news, one GPCR Event, and two GPCR job ads! GPCR University Our first Dr. GPCR at the Endocrine Metabolic GPCRs Summit on April 22-23, 2024, in Birmingham, UK. Dr. GPCR Ecosystem

GPCR Podcast Episode 154 of the Dr. tunes mGlu5 receptor function, impacting synaptic transmission Orphan receptor GPR88 as a potential therapeutic the neuropeptide Y4 receptor and its ligand pancreatic polypeptide from a structural, functional, and therapeutic News Structure Therapeutics Reports Positive Topline Data from its Phase 2a Obesity Study and Capsule GPCR Ecosystem

Hi GPCR lovers! GPCR University live Zoom sessions hosted by Dr. Terry Kenakin. , and more Structure, function and drug discovery of GPCR signaling Illuminating the understudied GPCR-ome Muscarinic Agonist Candidates in Phase 1 Clinical Studies AbbVie to acquire neuroscience drugmaker Cerevel Therapeutics GPCR Ecosystem

While GPCRs can exist as monomers, some types, like class C GPCRs, are obligate dimers, either as homodimers Class B1 GPCRs are an important subclass of GPCRs that include 15 receptors involved in regulating body for our understanding of GPCR function and signal transduction. for developing therapeutic agents that target specific receptor dimer states to modulate signaling in Graaf, C., et al., Glucagon-Like Peptide-1 and Its Class B G Protein-Coupled Receptors: A Long March to Therapeutic

Thus, identifying novel molecular targets for developing HF therapeutics remains a key research focus G protein-coupled receptors (GPCRs) are critical myocardial signal transducers which regulate cardiac therapeutics currently used in HF target these receptors. A recent focus on GPCR intracellular-regulating proteins such as GPCR kinases (GRKs) has uncovered GRK2 Read more at the source #DrGPCR #GPCR #IndustryNews

GPCR Symposia 2023. Adhesion GPCRs CryoEM structures of adhesion in GPCR CD97: Filling in some of the gaps GPCR Activation identification of potential agonists of FFAR4 for type 2 diabetes mellitus therapy Industry News OMass Therapeutics (ANDA) Litigation PostEra Announces a Research Collaboration with Amgen to Discover Small Molecule Therapeutics GPCR Ecosystem

October 2022 "Cannabinoid Receptor 2 (CB2) is a G protein-coupled receptor (GPCR) with considerable, though as yet unrealised, therapeutic potential. Read more at the source #DrGPCR #GPCR #IndustryNews

AlphaFold, homology modeling was the most common method for predicting G protein-coupled receptor (GPCR GPCRs are dynamic, switching between multiple conformations, and many have only distant homologs with The introduction of AlphaFold2 marked a major advancement in the field of GPCR structure prediction. While AlphaFold2’s ability to predict static structures was groundbreaking, however, GPCRs are highly crucial for understanding how drugs can selectively target different receptor conformations to achieve therapeutic

Hello GPCR people! We have great news! Take a few minutes, and dive into our GPCR coverage! We welcome GPCR paper suggestions! Adhesion GPCRs The Posttraumatic Increase in the Adhesion of GPCR EMR2/ ADGRE2 to Circulating Neutrophils Molecular sensing of mechano- and ligand-dependent adhesion GPCR dissociation GPCR Activation and Signaling GPCR Ecosystem

August 2022 "Cannabinoid Receptor 2 (CB2) is a G protein-coupled receptor (GPCR) with considerable, though as yet unrealized, therapeutic potential. Read more at the source #DrGPCR #GPCR #IndustryNews

We will be back next week with our regular weekly GPCR news digest. In the meantime, you can always check the  Classified GPCR News from the last weeks. GPCR Podcast. GPCR. Today is also the first session of our hands-on workshop with Dr. Sam Hoare. GPCR University content coming soon.

Are you ready for some exciting news in the GPCR world? This week's highlights: Dr. GPCR Symposium of the year on GPCRs in Immunology and Oncology! GPCR Newsletter for more insights! Company in Immuno-Oncology, Domain Therapeutics, Presents Groundbreaking Advancements at ESMO 2023 Novo GPCR Ecosystem

November 2022 "Adhesion G-protein-coupled receptors (aGPCRs) play key roles in a diversity of physiologies A hallmark of aGPCR activation is the removal of the inhibitory GAIN domain and the dipping of the cleaved The structures also reveal the uncharted structural information of GPCR/G12 coupling. Taken together, our study lays the groundwork for understanding aGPCR activation and G-protein-coupling Read more at the source #DrGPCR #GPCR #IndustryNews Subscribe to the Dr. GPCR Newsletter HERE

GPCR Newsletter to receive more insights! Adhesion GPCRs Piconewton Forces Mediate GAIN Domain Dissociation of the Latrophilin-3 Adhesion GPCR Unveiling Mechanical Activation: GAIN Domain Unfolding and Dissociation in Adhesion GPCRs GPCR Activation Tethered Ligands that Target the µ-Opioid Receptor Design and Synthesis of Novel GPR139 Agonists with Therapeutic GPCR Ecosystem

Human cells express over 800 G-protein-coupled receptors (GPCRs) to facilitate communication with the Capturing the dynamics of GPCR activation has always been a challenge because G protein activation in With this high-resolution, dynamic view of GPCR activation, scientists can better tackle diseases by puzzles and underscores the importance of understanding cellular processes at the molecular level for therapeutic Time-resolved cryo-EM of G-protein activation by a GPCR. Nature (2024).

ligands Essentials for effective GPCR discovery Discover: Advanced cellular assays for GPCR ligand behavior GPCR Event Highlight Join us in vibrant Mexico City from October 23-25, 2024, for the 11th Adhesion GPCR Let’s dive into the Classified GPCR News from July 22 to 28, 2024 GPCR Activation and Signaling Activating oligomers in live cells Industry News Confo Therapeutics Announces EUR 60M Series B Financing to Advance GPCR Ecosystem

GPCR Symposia Mark your calendars! GPCR Partnered Events April 22 - 23, 2024 | Endocrine Metabolic GPCRs Join the Endocrine Metabolic GPCRs Reviews, GPCRs, and more Butyrate as a promising therapeutic target in cancer: From pathogenesis to cadherin G protein-coupled receptors that bind cry toxins of Bacillus thuringiensis Industry News Domain Therapeutics GPCR Ecosystem

Read more at the source #DrGPCR #GPCR #IndustryNews Subscribe to the Newsletter HERE

GPCR podcast with Dr. Nicole (Nicki) Perry-Hauser is now available What a fun chat! GPCR Ecosystem paid membership to enjoy everything Dr. GPCR has! ➡️https://bit.ly/3TCJVQQ #gpcr #drgpcr

GPCR Symposium about 'GPCRs as Therapeutic Modalities' rocked it! GPCR Newsletter! Dive into the Classified GPCR News from September 18th to 24th, 2023. recommended by NICE for acute migraines Addex mGlu2 NAM Cognition Program Receives €4 Million Grant Confo Therapeutics Lefkowitz's Career at Duke October 3, 2023, | FREE Seminar: Changing paradigm on Therapeutics targeting GPCR Ecosystem

Xavier Leroy for his new role as CEO of GIO Therapeutics Dr. at the plasma membrane Industry News Launch of GIO Therapeutics, founded by Cumulus Oncology, to develop therapeutics targeting G protein-coupled receptors to treat cancer and inflammation AVROBIO and Tectonic Therapeutic Announce Merger Trevena Inc Elevates Barry Shin to Executive VP and CFO GPCR Events, Meetings GPCR Ecosystem

Our partner, Domain Therapeutics, will attend the SACHS 23rd annual biotech event in Europe. Dr. Christopher Langmead and colleagues' work on the 5-HT2C receptor as a therapeutic target for substance GPCR Symposium on ''GPCRs as Therapeutic Modalities' Share your project with a 1-minute abstract video Protein and Exendin-P5 Biased Agonist Molecular and structural insights into the 5-HT2C receptor as a therapeutic teams up with addiction treatment maker Indivior to make digital therapeutics for substance use disorders

GPCR University 🎥 Access to the recorded classes of GPCR Courses and talks from Symposia 💲 Discounted GPCR courses GPCR Forum Initiate a vibrant conversation or seek assistance GPCR Events to keep you Arm's Race' Developments Five protein-design questions that still challenge AI Prix Galien USA: Domain Therapeutics Nominated for the Prestigious Best Startup Award Tectonic Therapeutic Announces Positive Phase 1a Results Jobs Scientist I Cell Biology - Tectonic Therapeutic NEW Senior Principal Scientist, Medicinal Chemistry

in the GPCR field. GPCR Symposium on 'GPCRs as Therapeutic Modalities'. neutrophil chemoattractant Neuroimmune interplay during type 2 inflammation: symptoms, mechanisms and therapeutic Launches with $33 Million Seed Round to Fuel its Drug Discovery Engine and Pipeline of Small Molecule Therapeutics GPCR Ecosystem

network located on intracellular loop 2 that is subject to RNA editing, which differentially affects GPCR Read more at the source #DrGPCR #GPCR #IndustryNews

Get ready for an expedition, GPCR explorers! Welcome back to your weekly GPCR quest! Classified GPCR News  Let’s dive into the   Classified GPCR News from October 21st to 27th, 2024 Industry Emerging Voices in GPCR Biology in Special Issue of Molecular Pharmacology GPCR Events, Meetings, and Therapeutic PhD fellowship in GPCR mechanosensing Senior Scientist, GPCR Pharmacology Research Associate

that the affinity of Fzd for Dvl was not affected by Wnt ligands, in contrast to other members of the GPCR Read more at the source #DrGPCR #GPCR #IndustryNews

February 2022 Septerna emerges with $100M to spark 'second golden age' of prolific drug target GPCR with Better known as GPCR, the fruitful research space has led to more than 700 approved drugs over previous The company's co-founder, GPCR pioneer and Nobel laureate Robert Lefkowitz, M.D., has 50 years of experience Read more at the source #DrGPCR #GPCR #IndustryNews